Literature DB >> 10072478

Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics.

U Norinder1, T Osterberg, P Artursson.   

Abstract

A method for modeling and prediction of the intestinal absorption of drugs in humans using theoretically computed molecular descriptors and multivariate statistics has been investigated using 20 diverse drug-like compounds. The program MolSurf was used to compute theoretical molecular descriptors related to physicochemical properties such as lipophilicity, polarity, polarizability and hydrogen bonding. The multivariate Partial Least Squares Projections to Latent Structures (PLS) method was used to delineate the relationship between the intestinal absorption of drugs in humans and the theoretically computed molecular descriptors.Good statistical models were derived. Properties associated with hydrogen bonding had the largest impact on absorption and should be kept to a minimum to promote high absorption. High charge-transfer properties and the presence of surface electrons, i.e. valence electrons, which are not tightly bonded to the molecule, were also found to promote high absorption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072478     DOI: 10.1016/s0928-0987(98)00059-1

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

Review 1.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Neoflavonoids and tetrahydroquinolones as possible cancer chemopreventive agents.

Authors:  Suaib Luqman; Abha Meena; Pragya Singh; Tamara P Kondratyuk; Laura E Marler; John M Pezzuto; Arvind S Negi
Journal:  Chem Biol Drug Des       Date:  2012-07-25       Impact factor: 2.817

3.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

Review 4.  Advances in computationally modeling human oral bioavailability.

Authors:  Junmei Wang; Tingjun Hou
Journal:  Adv Drug Deliv Rev       Date:  2015-01-09       Impact factor: 15.470

5.  Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors.

Authors:  I-Jen Chen; Rajneesh Taneja; Daxu Yin; Paul R Seo; David Young; Alexander D MacKerell; James E Polli
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

6.  Predicting plasticization efficiency from three-dimensional molecular structure of a polymer plasticizer.

Authors:  M Tarvainen; R Sutinen; M Somppi; P Paronen; A Poso
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

Review 7.  Simulation Models for Prediction of Bioavailability of Medicinal Drugs-the Interface Between Experiment and Computation.

Authors:  Mahmoud E Soliman; Adeniyi T Adewumi; Oluwole B Akawa; Temitayo I Subair; Felix O Okunlola; Oluwayimika E Akinsuku; Shahzeb Khan
Journal:  AAPS PharmSciTech       Date:  2022-03-15       Impact factor: 3.246

8.  Computational approaches for modeling human intestinal absorption and permeability.

Authors:  Govindan Subramanian; Douglas B Kitchen
Journal:  J Mol Model       Date:  2006-04-01       Impact factor: 1.810

9.  Development of QSAR model for immunomodulatory activity of natural coumarinolignoids.

Authors:  Dharmendra K Yadav; Abha Meena; Ankit Srivastava; D Chanda; Feroz Khan; S K Chattopadhyay
Journal:  Drug Des Devel Ther       Date:  2010-09-07       Impact factor: 4.162

10.  Prediction of human intestinal absorption by GA feature selection and support vector machine regression.

Authors:  Aixia Yan; Zhi Wang; Zongyuan Cai
Journal:  Int J Mol Sci       Date:  2008-10-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.